SEARCH HEALTH CONDITIONS BY ALPHABETS
Familial Cold Urticaria
Medications for Familial Cold Autoinflammatory Syndrome
Other titles: Familial Cold Urticaria
About Familial Cold Autoinflammatory Syndrome: Familial Cold Autoinflammatory Syndrome is where urticaria, joint swelling and pain, chills, and fever develop following exposure to chilly
Drugs Used to Cure Familial Cold Autoinflammatory Syndrome
This listing of medications are found at the treatment of this condition, or in some way related to.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Arcalyst | Rx | C | N | Two reviews | 10 | ||
Generic name: rilonacept systemic Medication course: interleukin inhibitors For consumers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Ilaris | Rx | C | N | 1 inspection | 10 | ||
Generic name: canakinumab systemic Medication course: interleukin inhibitors For consumers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| canakinumab | Rx | C | N | 1 inspection | 10 | ||
Generic name: canakinumab systemic Brand name: Ilaris Medication course: interleukin inhibitors For consumers: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph | |||||||
| rilonacept | Rx | C | N | Two reviews | 10 | ||
Generic name: rilonacept systemic Brand name: Arcalyst Medication course: interleukin inhibitors For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Prizes | This medication might well not be accepted by the FDA for the treatment of the condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal research studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women obviously outweigh potential gains. |
| N | FDA has not classified this drug. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | Has a high potential for misuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| Two | Has a high potential for misuse. Includes a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may cause acute physical or emotional dependence. |
| 3 | features a potential for abuse less than people in schedules 1 and 2 two. Includes a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a minimal potential for abuse in accordance with people in schedule 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | Has a minimal potential for abuse in accordance with people in schedule 4. Includes a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to people in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Ep
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from your physician to make sure the information relates to your personal circumstances.
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Top USA Pharma Companies
Popular Categories
Health Condition
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Easily find an affordable health insurance plan
